Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03375086
Title A Study of APX3330 in Patients With Advanced Solid Tumors (APX3330)
Acronym APX3330
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Apexian Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University Simon Cancer Center Indianapolis Indiana 46202 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
START San Antonio San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field